Technical Analysis for SVRA - Savara, Inc.

Grade Last Price % Change Price Change
grade B 11.22 -3.77% -0.44
SVRA closed down 3.77 percent on Friday, November 17, 2017, on 2.74 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical SVRA trend table...

Date Alert Name Type % Chg
Nov 17 Bearish Engulfing Bearish 0.00%
Nov 17 Upper Bollinger Band Walk Other 0.00%
Nov 17 Slingshot Bullish Bullish Swing Setup 0.00%
Nov 16 New 52 Week Closing High Bullish -3.77%
Nov 16 Stochastic Sell Signal Bearish -3.77%

Older signals for SVRA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Savara Inc., formerly Mast Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Its pipeline includes AeroVanc, Molgradex and AIR001. AeroVanc is an inhaled formulation of vancomycin, which the Company is developing for the treatment of persistent methicillin-resistant Staphylococcus aureus, lung infection in cystic fibrosis patients. Molgradex is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor. It is developing Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis, a rare lung disease. AIR001 is a sodium nitrite solution for inhalation via nebulization. AIR001 is in Phase II clinical development for the treatment of heart failure with preserved ejection fraction, also known as diastolic heart failure or heart failure with preserved systolic function.
Is SVRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.1
52 Week Low 4.6
Average Volume 170,490
200-Day Moving Average 7.5058
50-Day Moving Average 9.2387
20-Day Moving Average 9.579
10-Day Moving Average 10.131
Average True Range 0.6322
ADX 18.68
+DI 34.88
-DI 17.83
Chandelier Exit (Long, 3 ATRs ) 10.2734
Chandelier Exit (Short, 3 ATRs ) 9.7466
Upper Bollinger Band 11.3456
Lower Bollinger Band 7.8124
Percent B (%b) 0.96
BandWidth 36.884852
MACD Line 0.5827
MACD Signal Line 0.3635
MACD Histogram 0.2192
Fundamentals Value
Market Cap 271.56 Million
Num Shares 24.2 Million
EPS -3.50
Price-to-Earnings (P/E) Ratio -3.21
Price-to-Sales 526.42
Price-to-Book 2.64
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.74
Resistance 3 (R3) 12.82 12.41 12.48
Resistance 2 (R2) 12.41 12.02 12.36 12.40
Resistance 1 (R1) 11.81 11.78 11.61 11.73 12.31
Pivot Point 11.40 11.40 11.29 11.35 11.40
Support 1 (S1) 10.80 11.01 10.60 10.72 10.13
Support 2 (S2) 10.39 10.77 10.34 10.04
Support 3 (S3) 9.79 10.39 9.96
Support 4 (S4) 9.71